Granicip 1 DT Tablet
Marketer
Cipla Ltd
Salt Composition
Granisetron (1mg)
Overview Granicip 1 DT Tablet
Ondansetron 1 DT Tablet, an antiemetic medication, effectively manages nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. This medication does not alleviate other cancer treatment side effects and is minimally effective against motion sickness. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Discontinue use only after consulting your doctor. If vomiting occurs within an hour of ingestion, repeat the dose and avoid large meals for the day. Common side effects include headache, constipation, diarrhea, and fatigue. Dizziness and drowsiness may also occur; avoid driving or mentally demanding tasks until the effects are known. These side effects typically resolve upon cessation; however, persistent or bothersome symptoms warrant medical consultation for management strategies. Prior to use, inform your doctor of any heart, liver, or gastrointestinal obstruction issues. Disclose all other medications, particularly those for epilepsy, cardiac conditions, cancer, or depression, as interactions may occur. Consult your healthcare provider if pregnant or breastfeeding.
Primary Ingredients of Granicip 1 DT Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Granicip 1 DT Tablet
Chemotherapy-induced emesis
Major Benefits of Granicip 1 DT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Granicip 1 DT Tablet in water before ingestion. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Granicip 1 DT Tablet:
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
How to use Granicip 1 DT Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Dissolve the tablet in water before consumption. Granicip 1 DT Tablets can be ingested with or without food; however, consistent timing is recommended.
How Granicip 1 DT Tablet works:
Granicip 1 DT Tablet counteracts nausea and vomiting. This antiemetic medication achieves its effect by inhibiting serotonin, a neurotransmitter in the brain responsible for triggering these symptoms, often experienced following surgery or during chemotherapy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granicip 1 DT Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Granicip 1 DT Tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Granicip 1 DT Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Granicip 1 DT Tablet.
KidneySAFE IF PRESCRIBED
The use of Granicip 1 DT Tablet in individuals with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Granicip 1 DT Tablet appears to pose minimal risk for individuals with liver conditions. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Granicip 1 DT Tablet :
Should you forget to take a Granicip 1 DT Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granicip 1 DT Tablet
| Label | Value |
|---|---|
| Chemical Category | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |





